Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-01-07 @ 12:30 PM
Study NCT ID:
NCT02131493
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2014-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
Sponsor:
Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01
Start Date Type:
None
Primary Completion Date:
2021-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-03
First Submit QC Date:
None
Study First Post Date:
2014-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-26
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL